- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case C-165/24 P: Appeal brought on 1 March 2024 by OmniActive Health Technologies Ltd against the judgment of the General Court (Eighth Chamber) delivered on 20 December 2023 in Joined Cases T-221/22 and T-242/22, Pharmaselect International and OmniActive Health Technologies v EUIPO – OmniActive Health Technologies and Pharmaselect International (LUTAMAX)
ECLI:EU:UNKNOWN:62024CN0165
62024CN0165
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
Official Journal of the European Union
C series
—
C/2024/4441
(Case C-165/24 P)
(C/2024/4441)
Language of the case: English
Parties
Appellant: OmniActive Health Technologies Ltd (represented by: M. Hawkins, abogado, and by C. Zimmer and T. Dolde, Rechtsanwälte)
Other parties to the proceedings: European Union Intellectual Property Office (EUIPO), Pharmaselect International Beteiligungs GmbH
By order of 14 June 2024, the Court of Justice (Chamber determining whether appeals may proceed) held that the appeal was not allowed to proceed and that OmniActive Health Technologies Ltd should bear its own costs.
—
ELI: http://data.europa.eu/eli/C/2024/4441/oj
ISSN 1977-091X (electronic edition)
—